Increased Interleukin-6 Activity Associated with Painful Chemotherapy-Induced Peripheral Neuropathy in Women after Breast Cancer Treatment
Figure 3
Mean levels of serum soluble gp130 in women with painful CIPN () and women without CIPN symptoms (Comparison Group, ). Dots represent mean value of soluble gp130 (sgp130) measured in serum; error bars represent 95% CI. Mean (SD), [Range] of the Painful CIPN group: 228.3 (112.7) ng/mL ; Comparison group: 350.8 (119.9) ng/mL . Independent t-test with Bonferroni correction performed to examine difference between groups: (t(38) = 4.2, ).